Affimed NV (AFMD)
5.31
-0.13
(-2.39%)
USD |
NASDAQ |
May 17, 16:00
5.31
0.00 (0.00%)
After-Hours: 20:00
Affimed Cash from Operations (Quarterly): -27.02M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -27.02M |
| September 30, 2023 | -19.76M |
| June 30, 2023 | -36.89M |
| March 31, 2023 | -35.71M |
| December 31, 2022 | -36.14M |
| September 30, 2022 | -16.00M |
| June 30, 2022 | -26.59M |
| March 31, 2022 | -31.89M |
| December 31, 2021 | -32.94M |
| September 30, 2021 | -29.29M |
| June 30, 2021 | -20.90M |
| March 31, 2021 | -19.32M |
| December 31, 2020 | 18.93M |
| September 30, 2020 | -6.348M |
| June 30, 2020 | -16.47M |
| March 31, 2020 | -18.26M |
| December 31, 2019 | 1.511M |
| September 30, 2019 | -12.76M |
| June 30, 2019 | -6.076M |
| March 31, 2019 | -15.20M |
| December 31, 2018 | 87.36M |
| September 30, 2018 | -10.88M |
| Date | Value |
|---|---|
| June 30, 2018 | -9.592M |
| March 31, 2018 | -8.505M |
| December 31, 2017 | -4.624M |
| September 30, 2017 | -9.916M |
| June 30, 2017 | -6.689M |
| March 31, 2017 | -7.706M |
| December 31, 2016 | -7.045M |
| September 30, 2016 | -9.331M |
| June 30, 2016 | -9.788M |
| March 31, 2016 | -9.394M |
| December 31, 2015 | -4.425M |
| September 30, 2015 | -7.471M |
| June 30, 2015 | -4.245M |
| March 31, 2015 | -4.428M |
| December 31, 2014 | -7.263M |
| September 30, 2014 | -1.966M |
| June 30, 2014 | -6.055M |
| March 31, 2014 | 1.259M |
| December 31, 2013 | -3.021M |
| September 30, 2013 | 3.556M |
| June 30, 2013 | -5.110M |
| March 31, 2013 | -2.966M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-36.89M
Minimum
Jun 2023
18.93M
Maximum
Dec 2020
-19.58M
Average
-19.76M
Median
Sep 2023
Cash from Operations (Quarterly) Benchmarks
| InflaRx NV | -16.15M |
| MorphoSys AG | -- |
| BioNTech SE | -344.65M |
| Immatics NV | -35.42M |
| CureVac NV | -45.82M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 1.755M |
| Cash from Financing (Quarterly) | -1.482M |
| Free Cash Flow | -123.42M |
| Free Cash Flow Per Share (Quarterly) | -1.842 |
| Free Cash Flow to Equity (Quarterly) | -26.63M |
| Free Cash Flow to Firm (Quarterly) | -27.55M |
| Free Cash Flow Yield | -157.3% |